Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.
- 2019-09-23
- Clinical Trial
- Digestive diseases and sciences 65(4)
- Grettel García-Collinot
- Eduardo Osiris Madrigal-Santillán
- Michel A Martínez-Bencomo
- Rosa A Carranza-Muleiro
- Luis J Jara
- Olga Vera-Lastra
- Daniel H Montes-Cortes
- Gabriela Medina
- María Pilar Cruz-Domínguez
- PubMed: 31549334
- DOI: 10.1007/s10620-019-05830-0
- High evidence
- Rigorous Journal
- Clinical
SIBO was eradicated in 55% of the M + SB group: 33% of SB, and 25% of M.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes